1. Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
   Mark Dapash et al, 2021, Cancers CrossRef
2. Multiple Faces of the Glioblastoma Microenvironment
   Alina Simona Șovrea et al, 2022, International Journal of Molecular Sciences CrossRef
3. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor–initiating cells
   Susobhan Sarkar et al, 2015, Neuro-Oncology CrossRef
4. Understanding current experimental models of glioblastoma-brain microenvironment interactions
   Niket Yadav et al, 2024, Journal of Neuro-Oncology CrossRef
5. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells
   Ming-Yu Zhou et al, 2021, World Journal of Gastroenterology CrossRef
6. Myeloid-Derived Suppressor Cells in Sepsis
   Dengming Lai et al, 2014, BioMed Research International CrossRef
7. The Tumorgenicity of Glioblastoma Cell Line U87MG Decreased During Serial In Vitro Passage
   Yu Zeng et al, 2018, Cellular and Molecular Neurobiology CrossRef
8. Recent Advances in Understanding Mechanisms of TGF Beta Signaling and Its Role in Glioma Pathogenesis
   Bozena Kaminska et al, 2020, Glioma Signaling CrossRef
9. A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems
   Jiaxi Xu et al, 2016, Frontiers in Physiology CrossRef
10. Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue
    Sander Bekeschus et al, 2022, Cancers CrossRef
11. TGFβ Signaling in the Tumor Microenvironment
    Cassandra Ringuette Goulet et al, 2021, Tumor Microenvironment CrossRef